SOLACI-CACI 2021 | Day 1: Main Arena Auditorium

✔️ Day 1, SOLACI-CACI 2021
✔️ Main Arena Auditorium

👨‍🏫 Program:

  • 06:20 – TCT@SOLACI-CACI 2021 Session – “The Future of PCI”
  • 01:33:19 – PCR@SOLACI-CACI 2021 Session
    👉 How to manage Coronary Artery Disease in patients with Severe Aortic Stenosis eligible for TAVI?
    👉 How to predict, how to avoid peri-procedural coronary obstruction during a TAVI procedure?
    👉 How to solve technical issues during PCI in a patient with a transcatheter heart valve previously implanted
  • 03:17:43 – Oral presentation – Structural I
  • 04:52:02 – Oral presentation – Coronary I
  • 06:14:52 – SCAI@SOLACI-CACI 2021 Session
  • 07:54:02 – Siemens Healthineers Symposium – “PCI image guidance and robotic automation for precise treatment”

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-CACI 2021 | Day 2: Main Arena Auditorium

✔️ Day 2, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:01 - TCT@SOLACI-CACI 2021 Session: "Structural Heart Interventions" 01:30:26 - CRT@SOLACI-CACI 2021 Session 02:51:13 - Oral...

SOLACI-CACI 2021 | Day 3: Main Arena Auditorium

✔️ Day 3 Completo, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:05 - CBS@SOLACI-CACI Session 01:43:26 - CCI@SOLACI-CACI Session 03:07:38 - Oral presentation – Structural III 04:32:21 -...

SOLACI-CACI 2021 | Day 4: Main Arena Auditorium

✔️ Day 4, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:09 - The MIL Group/SOLACI/CACI/WAO Gender Opportunities in Interventional Cardiology 01:30:55 - Current and Immediate...

SOLACI-CACI 2021 | Day 5: Salón Main Arena

✔️ Day 5, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:06 - DAPT Session 01:48:31 - Cardiovascular Disease Management and Cath Lab During the COVID-19...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...